Medications Recalled Due To Defective Product Packaging

Posted on

Manufacturers are tasked with creating products that meet the needs of the consumer. When it comes to medications, New Jersey consumers with children depend on these manufacturers to ensure that their products are made with the utmost emphasis on safety. Recently, the Consumer Product Safety Commission released a recall on several Triaminic and Theraflu products after problems were discovered with the child-resistant caps. Novartis Consumer Health, the manufacturer, voluntarily recalled the defective product.

According to reports, the recall is the result of an investigation into the problem with the caps. A consumer complaint was sent to Novartis in November. Federal law mandates that medications containing acetaminophen and diaphenhydramine must be packaged with child-resistant measures.

So far, 24 products have been recalled, including 142 lots of Triaminic Syrups and 41 lots of Theraflu Warming Syrups. Reports state that the recalled products were distributed between May 2010 and December 2011. So far, there have been 12 reports of children being able to unscrew the child-resistant caps. Four children ingested the product, according to reports, with one receiving medical attention.

With medications often being flavored, children are sometimes inclined to ingest them. Because of this, manufacturers must work diligently and consistently to ensure that proper labeling and packaging is in place. It only takes one defective product to cause poisoning or illness. New Jersey parents who believe that their child has fallen ill due to ingesting these recalled products may benefit from investigating their rights under New Jersey’s products liability laws to determine what their options may be to recover damages.

Source:, “Some Triaminic and Theraflu products recalled,” Saundra Young, Jan. 31, 2013

Recent BlogPosts

  • June, 2024

    Filing a Lawsuit for Tepezza-Related Hearing Loss

    Current Status of Tepezza Litigation – Class Action Lawsuit for Tepezza Numerous lawsuits against Horizon Therapeutics, the makers of Tepezza, are currently coordinated in multidistrict litigation (MDL) in federal court. The class action lawsuits arise from the drug’s connection to detrimental side effects, which include hearing loss, deafness, and tinnitus. The link between Tepezza and […]

  • May, 2024

    Medical Malpractice with Bariatric Surgery

    Gastric Bypass Surgery Malpractice Attorneys in New Jersey With nearly one-third of the adult population in the United States overweight or obese, it is no wonder that gastric bypass surgery is a standard procedure in hospitals across the nation. Individuals seeking weight loss undergo gastric bypass surgery, or stomach stapling, to help them with weight management that […]

  • May, 2024

    Determining if You May be Eligible for Compensation in an Ozempic Lawsuit

    Pending Litigation for Ozempic Complications and What it Could Mean for You Since its 2017 debut, Ozempic, a diabetes and weight loss drug, has attracted millions of innocent users. The semaglutide injectable is a prescription drug for Type 2 diabetics, but weight loss seekers also use the drug to regulate their sugar levels and manage […]


Free Case

  • This field is for validation purposes and should be left unchanged.